All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Analogues of Insulin, IGF1, and IGF2 for Studying the Biological Functions of Hormones and Their Receptors

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F25%3A00639671" target="_blank" >RIV/61388963:_____/25:00639671 - isvavai.cz</a>

  • Result on the web

    <a href="https://hdl.handle.net/11104/0370137" target="_blank" >https://hdl.handle.net/11104/0370137</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Analogues of Insulin, IGF1, and IGF2 for Studying the Biological Functions of Hormones and Their Receptors

  • Original language description

    Our research group at the Institute of Organic Chemistry and Biochemistry in Prague is focused on all aspects of insulin and insulin-like growth factors 1 and 2 (IGF1/2) physiology. Our general goal is to understand the structural basis for the different cellular responses triggered by insulin and IGFs. We synthesize analogs and mimetics of insulin and IGFs to study their interactions with cognate receptors and to develop new candidate drugs for the treatment of hormone-related disorders. In this lecture, I will summarize our results with insulin, IGF-1, and IGF-2 analogs that have modified binding affinities toward their cognate receptors, and I will demonstrate that these intriguing compounds can be highly useful for studying interactions and functional relationships within the insulin–IGF system, as well as for potential therapeutic applications.nThis publication was supported by the National Institute for Research on Metabolic and Cardiovascular Diseases (EXCELES Program, ID LX22NPO5104) – Funded by the European Union – Next Generation

  • Czech name

  • Czech description

Classification

  • Type

    O - Miscellaneous

  • CEP classification

  • OECD FORD branch

    10608 - Biochemistry and molecular biology

Result continuities

  • Project

    <a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů